The transcription factor X-box binding protein-1 in neurodegenerative diseases

Molecular Neurodegeneration

Volumn 9, Issue 1, 2014, Pages

  Dunys, Julie ^a,b   Duplan, Eric ^a,b   Checler, Frédéric ^a,b  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Alzheimer's disease; ER stress; Neurodegenerative diseases; Parkinson's disease; Unfolded Protein Response; X box binding protein 1

Indexed keywords

X BOX BINDING PROTEIN 1; DNA BINDING PROTEIN; REGULATORY FACTOR X TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; INFLAMMATORY DISEASE; METABOLIC DISORDER; NEOPLASM; PARKINSON DISEASE; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; ANIMAL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; DNA-BINDING PROTEINS; HUMANS; NEURODEGENERATIVE DISEASES; TRANSCRIPTION FACTORS; UNFOLDED PROTEIN RESPONSE;

EID: 84907434718     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-9-35     Document Type: Review

References (70)

1. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Hetz C, Nat Rev Mol Cell Biol 2012 13 89 102
2. The unfolded protein response: from stress pathway to homeostatic regulation. Walter P, Ron D, Science 2011 334 1081 1086
3. A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Liou HC, Boothby MR, Finn PW, Davidon R, Nabavi N, Zeleznik-Le NJ, Ting JP, Glimcher LH, Science 1990 247 1581 1584
4. The cellular response to protein misfolding in the endoplasmic reticulum. Welihinda AA, Tirasophon W, Kaufman RJ, Gene Expr 1999 7 293 300
5. Splicing: HACking into the unfolded-protein response. Shamu CE, Curr Biol 1998 8 121 R123
6. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG, Ron D, Nature 2002 415 92 96
7. Rapid turnover of unspliced Xbp-1 as a factor that modulates the unfolded protein response. Tirosh B, Iwakoshi NN, Glimcher LH, Ploegh HL, J Biol Chem 2006 281 5852 5860
8. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Lee K, Tirasophon W, Shen X, Michalak M, Prywes R, Okada T, Yoshida H, Mori K, Kaufman RJ, Genes Dev 2002 16 452 466
9. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K, Cell 2001 107 881 891
10. Lipid landscapes and pipelines in membrane homeostasis. Holthuis JC, Menon AK, Nature 2014 510 48 57
11. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. Hollien J, Lin JH, Li H, Stevens N, Walter P, Weissman JS, J Cell Biol 2009 186 323 331
12. Targeted disruption of CRE-binding factor TREB5 gene leads to cellular necrosis in cardiac myocytes at the embryonic stage. Masaki T, Yoshida M, Noguchi S, Biochem Biophys Res Commun 1999 261 350 356
13. Plasma cell differentiation requires the transcription factor XBP-1. Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F, Glimcher LH, Nature 2001 412 300 307
14. The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response. Iwakoshi NN, Lee AH, Glimcher LH, Immunol Rev 2003 194 29 38
15. An essential role in liver development for transcription factor XBP-1. Reimold AM, Etkin A, Clauss I, Perkins A, Friend DS, Zhang J, Horton HF, Scott A, Orkin SH, Byrne MC, Grusby MJ, Glimcher LH, Genes Dev 2000 14 152 157
16. Regulation of hepatic lipogenesis by the transcription factor XBP1. Lee AH, Scapa EF, Cohen DE, Glimcher LH, Science 2008 320 1492 1496
17. IRE1alpha-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis. Wang S, Chen Z, Lam V, Han J, Hassler J, Finck BN, Davidson NO, Kaufman RJ, Cell Metab 2012 16 473 486
18. XBP1 activates the transcription of its target genes via an ACGT core sequence under ER stress. Kanemoto S, Kondo S, Ogata M, Murakami T, Urano F, Imaizumi K, Biochem Biophys Res Commun 2005 331 1146 1153
19. Human HRD1 promoter carries a functional unfolded protein response element to which XBP1 but not ATF6 directly binds. Yamamoto K, Suzuki N, Wada T, Okada T, Yoshida H, Kaufman RJ, Mori K, J Biochem 2008 144 477 486
20. The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis. Sha H, He Y, Chen H, Wang C, Zenno A, Shi H, Yang X, Zhang X, Qi L, Cell Metab 2009 9 556 564
21. XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht BD, Mol Cell 2007 27 53 66
22. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS, Science 2004 306 457 461
23. Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction. Zhou Y, Lee J, Reno CM, Sun C, Park SW, Chung J, Fisher SJ, White MF, Biddinger SB, Ozcan U, Nat Med 2011 17 356 365
24. The other sweet face of XBP-1. Ueki K, Kadowaki T, Nat Med 2011 17 246 248
25. Mechanisms underlying hypertriglyceridemia in rats with monosodium L-glutamate-induced obesity: evidence of XBP-1/PDI/MTP axis activation. Franca LM, Freitas LN, Chagas VT, Coelho CF, Barroso WA, Costa GC, Silva LA, Debbas V, Laurindo FR, Paes AM, Biochem Biophys Res Commun 2014 443 725 730
26. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice. Ye D, Li FY, Lam KS, Li H, Jia W, Wang Y, Man K, Lo CM, Li X, Xu A, Gut 2012 61 1058 1067
27. TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes. Savic S, Ouboussad L, Dickie LJ, Geiler J, Wong C, Doody GM, Churchman SM, Ponchel F, Emery P, Cook GP, Buch MH, Tooze RM, McDermott MF, Buch MH, Tooze RM, McDermott MF, J Autoimmun 2014 50 59 66
28. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, Tilg H, Nieuwenhuis EE, Higgins DE, Schreiber S, Glimcher LH, Blumberg RS, Cell 2008 134 743 756
29. Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival. Tang CH, Ranatunga S, Kriss CL, Cubitt CL, Tao J, Pinilla-Ibarz JA, Del Valle JR, Hu CC, J Clin Invest 2014 124 2585 2598
30. XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, Lim E, Tam WL, Ni M, Chen Y, Mai J, Shen H, Hu DZ, Adoro S, Hu B, Song M, Tan C, Landis MD, Ferrari M, Shin SJ, Brown M, Chang JC, Liu XS, Glimcher LH, Nature 2014 508 103 107
31. Activation and clinical significance of the unfolded protein response in breast cancer. Scriven P, Coulson S, Haines R, Balasubramanian S, Cross S, Wyld L, Br J Cancer 2009 101 1692 1698
32. Upregulation and overexpression of human X-box binding protein 1 (hXBP-1) gene in primary breast cancers. Fujimoto T, Onda M, Nagai H, Nagahata T, Ogawa K, Emi M, Breast Cancer 2003 10 301 306
33. Overexpression of human X-box binding protein 1 (XBP-1) in colorectal adenomas and adenocarcinomas. Fujimoto T, Yoshimatsu K, Watanabe K, Yokomizo H, Otani T, Matsumoto A, Osawa G, Onda M, Ogawa K, Anticancer Res 2007 27 127 131
34. Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy. Vidal RL, Figueroa A, Court FA, Thielen P, Molina C, Wirth C, Caballero B, Kiffin R, Segura-Aguilar J, Cuervo AM, Glimcher LH, Hetz C, Hum Mol Genet 2012 21 2245 2262
35. The ER stress factor XBP1s prevents amyloid-beta neurotoxicity. Casas-Tinto S, Zhang Y, Sanchez-Garcia J, Gomez-Velazquez M, Rincon-Limas DE, Fernandez-Funez P, Hum Mol Genet 2011 20 2144 2160
36. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease. Reinhardt S, Schuck F, Grosgen S, Riemenschneider M, Hartmann T, Postina R, Grimm M, Endres K, Faseb J 2013 28 978 997
37. Induction of the unfolded protein response and cell death pathway in Alzheimer's disease, but not in aged Tg2576 mice. Lee JH, Won SM, Suh J, Son SJ, Moon GJ, Park UJ, Gwag BJ, Exp Mol Med 2010 42 386 394
38. Polymorphism -116C/G of human X-box-binding protein 1 promoter is associated with risk of Alzheimer's disease. Liu SY, Wang W, Cai ZY, Yao LF, Chen ZW, Wang CY, Zhao B, Li KS, CNS Neurosci Ther 2013 19 229 234
39. Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. Valdes P, Mercado G, Vidal RL, Molina C, Parsons G, Court FA, Martinez A, Galleguillos D, Armentano D, Schneider BL, Hetz C, Proc Natl Acad Sci U S A 2014 111 6804 6809
40. ER-stress-associated functional link between Parkin and DJ-1 via a transcriptional cascade involving the tumor suppressor p53 and the spliced X-box binding protein XBP-1. Duplan E, Giaime E, Viotti J, Sevalle J, Corti O, Brice A, Ariga H, Qi L, Checler F, da Costa CA, J Cell Sci 2013 126 2124 2133
41. Differential activation of the ER stress factor XBP1 by oligomeric assemblies. Castillo-Carranza DL, Zhang Y, Guerrero-Munoz MJ, Kayed R, Rincon-Limas DE, Fernandez-Funez P, Neurochem Res 2012 37 1707 1717
42. Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. Atkin JD, Farg MA, Turner BJ, Tomas D, Lysaght JA, Nunan J, Rembach A, Nagley P, Beart PM, Cheema SS, Horne MK, J Biol Chem 2006 281 30152 30165
43. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Hetz C, Thielen P, Matus S, Nassif M, Court F, Kiffin R, Martinez G, Cuervo AM, Brown RH, Glimcher LH, Genes Dev 2009 23 2294 2306
44. The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Park SW, Zhou Y, Lee J, Lu A, Sun C, Chung J, Ueki K, Ozcan U, Nat Med 2010 16 429 437
45. A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response. Winnay JN, Boucher J, Mori MA, Ueki K, Kahn CR, Nat Med 2010 16 438 445
46. XBP-1u suppresses autophagy by promoting the degradation of FoxO1 in cancer cells. Zhao Y, Li X, Cai MY, Ma K, Yang J, Zhou J, Fu W, Wei FZ, Wang L, Xie D, Zhu WG, Cell Res 2013 23 491 507
47. The role of X-box binding protein-1 in tumorigenicity. Shajahan AN, Riggins RB, Clarke R, Drug News Perspect 2009 22 241 246
48. IRE1alpha controls cyclin A1 expression and promotes cell proliferation through XBP-1. Thorpe JA, Schwarze SR, Cell Stress Chaperones 2010 15 497 508
49. The natural history of motoneuron loss in amyotrophic lateral sclerosis. Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L, Neurology 1988 38 409 413
50. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Huntington's Disease Collaborative Research Group, Cell 1993 72 971 983
51. Identification of an expanded CAG repeat in the Huntington's disease gene (IT15) in a family reported to have benign hereditary chorea. MacMillan JC, Morrison PJ, Nevin NC, Shaw DJ, Harper PS, Quarrell OW, Snell RG, J Med Genet 1993 30 1012 1013
52. CAG repeat size and clinical presentation in Huntington's disease. Ashizawa T, Wong LJ, Richards CS, Caskey CT, Jankovic J, Neurology 1994 44 1137 1143
53. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux. Lee H, Noh JY, Oh Y, Kim Y, Chang JW, Chung CW, Lee ST, Kim M, Ryu H, Jung YK, Hum Mol Genet 2012 21 101 114
54. Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Duennwald ML, Lindquist S, Genes Dev 2008 22 3308 3319
55. AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease. Zuleta A, Vidal RL, Armentano D, Parsons G, Hetz C, Biochem Biophys Res Commun 2012 420 558 563
56. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. Unterberger U, Hoftberger R, Gelpi E, Flicker H, Budka H, Voigtlander T, J Neuropathol Exp Neurol 2006 65 348 357
57. The unfolded protein response is activated in Alzheimer's disease. Hoozemans JJ, Veerhuis R, Van Haastert ES, Rozemuller JM, Baas F, Eikelenboom P, Scheper W, Acta Neuropathol 2005 110 165 172
58. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W, Am J Pathol 2009 174 1241 1251
59. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Katayama T, Imaizumi K, Sato N, Miyoshi K, Kudo T, Hitomi J, Morihara T, Yoneda T, Gomi F, Mori Y, Nakano Y, Takeda J, Tsuda T, Itoyama Y, Murayama O, Takashima A, St George-Hyslop P, Takeda M, Tohyama M, Nat Cell Biol 1999 1 479 485
60. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA, Nature 2006 441 513 517
61. Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. Checler F, J Neurochem 1995 65 1431 1444
62. Loss of HRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloid-beta generation. Kaneko M, Koike H, Saito R, Kitamura Y, Okuma Y, Nomura Y, J Neurosci 2010 30 3924 3932
63. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, Greene LA, J Neurosci 2002 22 10690 10698
64. Activation of the unfolded protein response in Parkinson's disease. Hoozemans JJ, van Haastert ES, Eikelenboom P, de Vos RA, Rozemuller JM, Scheper W, Biochem Biophys Res Commun 2007 354 707 711
65. Protective effect against Parkinson's disease-related insults through the activation of XBP1. Sado M, Yamasaki Y, Iwanaga T, Onaka Y, Ibuki T, Nishihara S, Mizuguchi H, Momota H, Kishibuchi R, Hashimoto T, Wada D, Kitagawa H, Watanabe TK, Brain Res 2009 1257 16 24
66. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P, Science 2003 299 256 259
67. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T, Nat Genet 2000 25 302 305
68. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. da Costa CA, Sunyach C, Giaime E, West A, Corti O, Brice A, Safe S, Abou-Sleiman PM, Wood NW, Takahashi H, Goldberg MS, Shen J, Checler F, Nat Cell Biol 2009 11 1370 1375
69. S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's disease. Sunico CR, Nakamura T, Rockenstein E, Mante M, Adame A, Chan SF, Newmeyer TF, Masliah E, Nakanishi N, Lipton SA, Mol Neurodegener 2013 8 29
70. p53 in neurodegenerative diseases and brain cancers. Checler F, Alves da Costa C, Pharmacol Ther 2014 142 99 113